UCB revenue breakdown overview

UCB revenue for the last year amounted to 4.88 B CHF, the most of which — 4.52 B CHF — came from its highest performing source at the moment, Biopharmaceuticals, the year earlier bringing 5.09 B CHF. The greatest contribution to the revenue figure was made by United States — last year it brought UCB 2.28 B CHF, and the year before that — 2.87 B CHF.